The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice
Reproduction · 2023
DOI: 10.1530/rep-22-0355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2023. Verfasst von Katharine Cecchini und 12 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Placenta, Transcription Factors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Howard Hughes Medical Institute, NIGMS NIH HHS.
Abstract (Originalsprache)
In brief The testis-specific transcription factor, TCFL5, expressed in pachytene spermatocytes regulates the meiotic gene expression program in collaboration with the transcription factor A-MYB. Abstract In male mice, the transcription factors STRA8 and MEISON initiate meiosis I. We report that STRA8/MEISON activates the transcription factors A-MYB and TCFL5, which together reprogram gene expression after spermatogonia enter into meiosis. TCFL5 promotes the transcription of genes required for meiosis, mRNA turnover, miR-34/449 production, meiotic exit, and spermiogenesis. This transcriptional architecture is conserved in rhesus macaque, suggesting TCFL5 plays a central role in meiosis and spermiogenesis in placental mammals. Tcfl5em1/em1 mutants are sterile, and spermatogenesis arrests at the mid- or late-pachytene stage of meiosis. Moreover, Tcfl5+/em1 mutants produce fewer motile sperm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RNA Therapeutics Institute and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
- Beam Therapeutics, Cambridge, Massachusetts, USA.
- Voyager Therapeutics, Cambridge, Massachusetts, USA.
ORCID-Profile: Phillip D Zamore, Deniz M Özata
Förderung
- NICHD NIH HHS
- Howard Hughes Medical Institute
- NIGMS NIH HHS
- NIH HHS
Zitieren
APA
Cecchini, K., Biasini, A., Yu, T., Säflund, M., Mou, H., Arif, A., Eghbali, A., Colpan, C., Gainetdinov, I., de Rooij, D. G., Weng, Z., Zamore, P. D., & Özata, D. M. (2023). The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice. Reproduction. https://doi.org/10.1530/rep-22-0355
Vancouver
Cecchini K, Biasini A, Yu T, Säflund M, Mou H, Arif A, et al. The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice. Reproduction. 2023. doi:10.1530/rep-22-0355
BibTeX
@article{Cecchini2023,
author = {Cecchini, Katharine and Biasini, Adriano and Yu, Tianxiong and Säflund, Martin and Mou, Haiwei and Arif, Amena and Eghbali, Atiyeh and Colpan, Cansu and Gainetdinov, Ildar and de Rooij, Dirk G and Weng, Zhiping and Zamore, Phillip D and Özata, Deniz M},
title = {The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice},
journal = {Reproduction},
year = {2023},
doi = {10.1530/rep-22-0355}
}
EUVIMED